News

Meet the Wyoming company that could halt Parkinson’s disease – Nitrome Biosciences

Nitrome Biosciences is developing drugs against a new class of enzymes, initially targeting Parkinson’s disease. When successful, we will have found and characterized a new class of enzymes and will have a proprietary development path for disease-modifying drugs for multiple aging-dependent diseases. We are starting with Parkinson’s disease but this may be extended to include other neurodegenerative diseases, heart disease and cancer.

NITROME BIOSCIENCES, INC

435 Henley Rd

P.O. Box 4971

Jackson, WY 83001

USA

https://vimeo.com/nitromebiosciences/about

Posted in:

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.